Comprehensive 2026 Review Updates Pharmacology, Biosynthesis and Biotechnology of Nine Mitragyna Species

Why it matters

This open-access review synthesizes the latest pharmacology of mitragynine, rhynchophylline, and other key alkaloids across nine Mitragyna species — providing researchers and clinicians with an updated scientific foundation as regulatory debates intensify.

The big picture

Research on Mitragyna speciosa and related species has expanded rapidly since 2022, but most attention has focused narrowly on mitragynine and 7-hydroxymitragynine. This comprehensive review fills a gap by covering all nine Mitragyna species and their phytochemical constituents, while also addressing biotechnological strategies to enhance sustainable alkaloid production — a critical consideration as demand for kratom research compounds grows.

Key findings

• Review covers nine Mitragyna species: M. speciosa, M. diversifolia, M. stipulosa, M. rubrostipulosa, M. inermis, M. hirsuta, M. parvifolia, M. rotundifolia, and M. tubulosa
• Pharmacological studies of mitragynine, rhynchophylline, and isorhynchophylline showed effects on CNS, cardiovascular, digestive, and peripheral nervous systems
• Updated biosynthetic pathways for both indole and spirooxindole alkaloids are documented
• Plant biotechnology strategies including media manipulation, precursor feeding, and elicitation offer paths to enhanced alkaloid production
• Metabolic engineering and synthetic biology platforms provide sustainable alternatives for pharmaceutical research and development
• Published open access under Creative Commons license, enabling broad scientific use

What they say

The authors conclude that "metabolic engineering and synthetic biology of mitragyna alkaloids can provide a more sustainable, consistent and scalable alternative which holds significant potential in scientific research and pharmaceutical developments."

Bottom line

**This open-access review provides the most comprehensive update since 2022 on Mitragyna alkaloid pharmacology and biosynthesis, giving researchers a scientific baseline as policy debates demand clearer evidence.**